Company profile: Wacker Chemie
1.1 - Company Overview
Company description
- Provider of silicone products (emulsions, rubber, silica) for electronics and automotive; polymer solutions for construction, adhesives and coatings; high-purity polysilicon for semiconductor and solar; biotechnology products and services including biopharmaceuticals and food ingredients; plus technical competence centers offering expert advice and product development support.
Products and services
- WACKER SILICONES: Industrial-grade range of silicone emulsions, rubber, and silica for electronics and automotive applications across various industries
- WACKER POLYSILICON: High-purity polysilicon produced for the semiconductor and solar industries, supporting the production of electronic components and solar cells
- WACKER POLYMERS: Application-specific polymer products supplied for construction, adhesives, and coatings, focusing on products for diverse applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Wacker Chemie
PharmaLex
HQ: Germany
Website
- Description: Provider of specialized services for pharma, biotech and medtech, from early strategic planning and non-clinical requirements through discovery and clinical development, regulatory submissions and commercialization, to post-approval maintenance. Offerings include integrated product development, market access, post-launch outsourcing to optimize compliance and global market coverage, local affiliate support, AI/ML-driven innovation, and PharmaLearn training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaLex company profile →
ThreeWire
HQ: United States
Website
- Description: Provider of customized clinical trial recruitment, enrollment and retention solutions for the pharmaceutical, biotech and medical device industries, addressing enrollment targets and study delays, and offering direct-to-patient marketing services for medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ThreeWire company profile →
Velocity Clinical Research
HQ: United States
Website
- Description: Provider of clinical trial management; patient recruitment and retention; and in-house laboratory services to deliver high-quality clinical trial data. Offers technology solutions (VISION Recruit, VISION Engage) to streamline clinical trial processes and improve patient experiences, consumer product safety and efficacy testing, and sustainability initiatives to reduce environmental impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Velocity Clinical Research company profile →
Marvel Biotechnology
HQ: Canada
Website
- Description: Provider of biotech discovery and development of synthetic derivatives of proven drugs, including MB-204, a fluorinated derivative of istradefylline, for neurological diseases (depression, anxiety, Alzheimer's, ADHD), liver fibrosis due to NASH, and adjunctive cancer therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marvel Biotechnology company profile →
Ten23 Health
HQ: Switzerland
Website
- Description: Provider of biologics drug product contract development and manufacturing services focused on injectable treatments. Offers sterile product manufacturing using isolator technology; clinical fill-finish and commercial supplies for vials, syringes, and cartridges; manufacturing process transfer, characterization, and validation; stability samples, reference standards, and pre-clinical supplies; and analytical testing and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ten23 Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Wacker Chemie
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Wacker Chemie
2.2 - Growth funds investing in similar companies to Wacker Chemie
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Wacker Chemie
4.2 - Public trading comparable groups for Wacker Chemie
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →